Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Ann Arbor, Michigan 48109


Patients with rheumatoid arthritis have a significantly higher risk to develop heart attacks and other complications of their blood vessels. New therapies are needed to prevent this complication. The purpose of this study is to establish the role of the medication pioglitazone in improving the function of the blood vessels and heart and decreasing the risk of future atherosclerosis development in individuals with rheumatoid arthritis. As a secondary aim-point, we will evaluate the efficacy of pioglitazone in improving rheumatoid arthritis disease activity and markers of inflammation.

Study summary:

This study will establish the role of pioglitazone in improvement of endothelial function, arterial compliance and disease activity in patients with rheumatoid arthritis. This will be a placebo-controlled, double blind, cross-over trial.


Inclusion Criteria: - Women on adequate contraception if they are of child-bearing age. - Meet revised ACR criteria for RA. - Stable doses of DMARDS,biologic agents and or corticosteroids for at least 3 months. Exclusion Criteria: - Pregnant or lactating women. - Current smokers or individuals who smoked in the last 6 months. - Diagnosis of Diabetes, heart failure, or infection. - Current diagnosis of malignant disease except for basal cell or squamous cell carcinoma of the skin. - No active liver disease. - No cholesterol-lowering medications or oral hypoglycemic agents.



Primary Contact:

Principal Investigator
Mariana J Kaplan, MD
University of Michigan

Backup Contact:


Location Contact:

Ann Arbor, Michigan 48109
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: February 04, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.